Skip to main content

Table 1 Baseline characteristic of the study participantsa

From: Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes

Variables TB (n = 40) TB-DM (n = 40) p-valueb Healty Controls (n = 20) p-valuec p-valued
Sex, Male (n, %) 29 (75.5) 39 (97.5) 0.0024 14 (70.0) 0.466 < 0.001
Age (years) 26.6 ± 7.6 40.1 ± 8.8 < 0.0001 32.5 ± 6.3 0.036 0.030
BMI (Kg/m2) 17.6 ± 2.7 21.7 ± 2.5 < 0.001 26.1 ± 3.9 < 0.001 < 0.005
Family SES
 1st tertile (poor), n (%) 19 (47.5) 8 (20.00)   0   
 2nd tertile (middle), n (%) 13 (32.5) 15 (37.5)   3   
 3rd tertile (rich), n (%) 8 (20.00) 17 (42.5)   17   
BCG vaccination status, n (%) 23 (57.5) 35 (87.5) < 0.0025 18 (90.0) 0.023 0.775
History of contact with active cases 19 (54.3%) 16 (45.7%) 0.255   
Duration of Symptom (days) 61 (30, 105.5) 75.5 (60, 121) 0.087   
Sputum smear results (AFB), n (%)
eAFB negative 0 2 (5%)    
  1+ AFB 9 (22.5%) 10 (25.0%)    
  2+ AFB 11 (27.5%) 9 (22.5%)    
  3+ AFB 20 (50.0%) 19 (47.5%)    
  1. aQuantitative data are presented as median ± IQR; Categorical data are presented as n (%). Statistical analysis comparing bTB vs TB-DM, cTB vs HC, and dTB-DM vs HC was done using Chi-square, Kruskal-Wallis and Dunn’s post-test or the Mann-Whitney U-test eSputum samples positive in the GeneXpert MTB/RIF test. AFB: Acid-Fast Bacilli; BCG: Bacillus Calmette–Guérin; BMI: body mass index; SES: socioeconomic status